tiprankstipranks
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO

Aptevo Therapeutics (APVO) Financial Statements

364 Followers

Aptevo Therapeutics Financial Overview

Aptevo Therapeutics's market cap is currently ―. The company's EPS TTM is $-99.398; its P/E ratio is >-0.01; Aptevo Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-1.93. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.83M$ -6.20M$ -6.33M$ -7.95M$ 1.83M
EBITDA$ -6.73M$ -6.08M$ -6.21M$ -7.80M$ 2.00M
Net Income Common Stockholders$ -6.83M$ -5.90M$ -6.33M$ -7.95M$ 2.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.25M$ 16.90M$ 19.11M$ 21.01M$ 25.33M
Total Assets$ 17.63M$ 24.84M$ 27.13M$ 28.91M$ 34.97M
Total Debt$ 5.20M$ 5.40M$ 5.60M$ 5.70M$ 5.90M
Net Debt$ -5.05M$ -11.50M$ -13.51M$ -15.31M$ -19.43M
Total Liabilities$ 11.53M$ 12.62M$ 12.41M$ 12.61M$ 11.71M
Stockholders Equity$ 6.10M$ 12.22M$ 14.72M$ 16.25M$ 23.26M
Cash Flow-
Free Cash Flow$ -6.65M$ -5.25M$ -6.24M$ -4.80M$ 4.57M
Operating Cash Flow$ -6.65M$ -5.25M$ -6.24M$ -4.80M$ 4.57M
Investing Cash Flow-----
Financing Cash Flow$ -3.00K$ 3.05M$ 4.34M$ 481.00K$ -1.87M
Currency in USD

Aptevo Therapeutics Earnings and Revenue History

Aptevo Therapeutics Debt to Assets

Aptevo Therapeutics Cash Flow

Aptevo Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis